![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » HBM BioVentures Acquires Shares of Aspreva Pharmaceuticals
HBM BioVentures Acquires Shares of Aspreva Pharmaceuticals
HBM BioVentures (Cayman) Ltd. announced that it has purchased an additional 3,964,615 common shares of Aspreva Pharmaceuticals Corporation (Aspreva), or approximately 12 percent of such shares outstanding based on the 32,948,378 common shares outstanding on March 3, 2005 in connection with the initial public offering of Aspreva, which closed on March 9, 2005.
Big News Network (http://feeds.bignewsnetwork.com/redir.php?jid=2f07c28d8e1cb5d5&cat=6dcd932030878143)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct